South China Journal of Preventive Medicine ›› 2020, Vol. 46 ›› Issue (4): 351-354.doi: 10.12183/j.scjpm.2020.0351

• Original Article • Previous Articles     Next Articles

Mortality and influencing factors among people living with HIV and AIDS in Longgang District, Shenzhen

YANG Yong-ping1, LI Xiao-xia2, ZHAOJin3, LIU Qu2, XIE Xian-qing2, LONG Qing-ping2   

  1. 1. Preventive Care of Pingdi of Longgang District, Shenzhen 518117, China;
    2. Shenzhen Longgang District Center for Disease Control and Prevention;
    3. Shenzhen Center for Disease Control and Prevention
  • Received:2020-01-20 Online:2020-08-20 Published:2020-09-16

Abstract: Objective To understand the death status of people living with HIV/AIDS and analyze the related influencing factors in Longgang District, Shenzhen. Methods HIV/AIDS patients with current residential address in Longgang District, Shenzhen City from January 1, 2010 to December 31, 2018 were selected through the China information system for HIV/AIDS comprehensive prevention and control. Cox proportional hazard model was used to analyze the factors influencing the death on HIV/AIDS cases. Results A total of 590 HIV/AIDS cases were chosen, including 236 deaths (187 males and 49 females). Multi-factor Cox regression analysis showed that the risk of death in married, divorced or widowed persons was 0.003 time and 0.418 time that in unmarried persons; the mortality risk of AIDS patients at diagnosis was 9.149 times that of HIV-infected persons; the risk of death from heterosexual transmission, homosexual transmission, and blood collection and supply was 0.319, 0.079, and 0.004 times that of injecting drug use, respectively; the risk of death in those who were not tested for CD4 was 9.166 times that in those who were tested; the risk of death in patients receiving antiviral therapy was 0.052 time that in patients without antiviral therapy. Conclusion The mortality of HIV/AIDS cases in Longgang District, Shenzhen City was affected by many factors. Of them, CD4 testing and antiretroviral therapy could effectively reduce the risk of mortality among HIV/AIDS cases.

Key words: HIV/AIDS, Mortality, Influencing factors

CLC Number: 

  • R512.91